| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Active metabolite from Tamiflu® solution is bioequivalent to that from capsule delivery in healthy volunteers: A cross-over, randomised, open-label study
|
Brewster, M.
|
|
2006
|
24 |
44-46 |
p. 6660-6663
4 p.
|
article
|
| 2 |
An emerging avian influenza A virus H5N7 is a genetic reassortant of highly pathogenic genes
|
Bragstad, K.
|
|
2006
|
24 |
44-46 |
p. 6736-6741
6 p.
|
article
|
| 3 |
An influenza A/H3 outbreak during the 2004/2005 winter in elderly vaccinated people living in a nursing home
|
Iorio, A.M.
|
|
2006
|
24 |
44-46 |
p. 6615-6619
5 p.
|
article
|
| 4 |
Burden of upper respiratory illnesses among college and university students: 2002–2003 and 2003–2004 cohorts
|
Nichol, K.L.
|
|
2006
|
24 |
44-46 |
p. 6724-6725
2 p.
|
article
|
| 5 |
Chapter II: Conclusions of the workshops of the Second European Influenza Conference
|
Vanlangendonck, Chris
|
|
2006
|
24 |
44-46 |
p. 6761-
1 p.
|
article
|
| 6 |
Chapter I: Proceedings of the scientific sessions
|
|
|
2006
|
24 |
44-46 |
p. 6576-
1 p.
|
article
|
| 7 |
Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses
|
Lu, Xiuhua
|
|
2006
|
24 |
44-46 |
p. 6588-6593
6 p.
|
article
|
| 8 |
Development of H5-RT-LAMP (loop-mediated isothermal amplification) system for rapid diagnosis of H5 avian influenza virus infection
|
Imai, Masaki
|
|
2006
|
24 |
44-46 |
p. 6679-6682
4 p.
|
article
|
| 9 |
Diagnosis and Treatment of Influenza in primary healthcare: "You can't manage what you can't measure"
|
|
|
2006
|
24 |
44-46 |
p. 6785-6790
6 p.
|
article
|
| 10 |
Early detection of A/California/7/2004-like A(H3N2) strains in Norway during the 2004–2005 season, and emergence of a novel H3N2 genetic sub-variant toward the end
|
Hungnes, Olav
|
|
2006
|
24 |
44-46 |
p. 6694-6696
3 p.
|
article
|
| 11 |
Economic and Social Impact of Epidemic and Pandemic Influenza
|
|
|
2006
|
24 |
44-46 |
p. 6776-6778
3 p.
|
article
|
| 12 |
Editorial
|
Osterhaus, A.D.M.E.
|
|
2006
|
24 |
44-46 |
p. 6575-
1 p.
|
article
|
| 13 |
Editorial Board
|
|
|
2006
|
24 |
44-46 |
p. CO2-
1 p.
|
article
|
| 14 |
Effectiveness of influenza vaccination: A survey within the Italian Ministry of Health personnel
|
Rizzuto, E.
|
|
2006
|
24 |
44-46 |
p. 6612-6614
3 p.
|
article
|
| 15 |
Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3–14 years: A prospective cohort study
|
Salleras, L.
|
|
2006
|
24 |
44-46 |
p. 6638-6642
5 p.
|
article
|
| 16 |
Epidemic and Pandemic Influenza, WHO Cares and HOW?
|
|
|
2006
|
24 |
44-46 |
p. 6762-6765
4 p.
|
article
|
| 17 |
Estimation of the reproductive number of the Spanish flu epidemic in Geneva, Switzerland
|
Chowell, G.
|
|
2006
|
24 |
44-46 |
p. 6747-6750
4 p.
|
article
|
| 18 |
Etiology of influenza viruses isolated in Russia from 1998 up to present time
|
Konovalova, N.I.
|
|
2006
|
24 |
44-46 |
p. 6697-6700
4 p.
|
article
|
| 19 |
Evidence for specific packaging of the influenza A virus genome from conditionally defective virus particles lacking a polymerase gene
|
de Wit, Emmie
|
|
2006
|
24 |
44-46 |
p. 6647-6650
4 p.
|
article
|
| 20 |
Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005
|
Ferraris, Olivier
|
|
2006
|
24 |
44-46 |
p. 6656-6659
4 p.
|
article
|
| 21 |
Fitness costs limit escape from cytotoxic T lymphocytes by influenza A viruses
|
Berkhoff, E.G.M.
|
|
2006
|
24 |
44-46 |
p. 6594-6596
3 p.
|
article
|
| 22 |
Heterogeneity of case definitions used in vaccine effectiveness studies—And its impact on meta-analysis
|
Beyer, Walter E.P.
|
|
2006
|
24 |
44-46 |
p. 6602-6604
3 p.
|
article
|
| 23 |
Heterogeneity of influenza case definitions and implications for interpreting and comparing study results
|
Nichol, Kristin L.
|
|
2006
|
24 |
44-46 |
p. 6726-6728
3 p.
|
article
|
| 24 |
High prevalence of influenza A virus in ducks caught during spring migration through Sweden
|
Wallensten, Anders
|
|
2006
|
24 |
44-46 |
p. 6734-6735
2 p.
|
article
|
| 25 |
How to develop and implement pandemic preparedness plans? The need for a coherent European policy
|
|
|
2006
|
24 |
44-46 |
p. 6766-6769
4 p.
|
article
|
| 26 |
Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma
|
Brydak, Lidia B.
|
|
2006
|
24 |
44-46 |
p. 6620-6623
4 p.
|
article
|
| 27 |
Identification of genetic diversity by cultivating influenza A(H3N2) virus in vitro in the presence of post-infection sera from small children
|
Haaheim, L.R.
|
|
2006
|
24 |
44-46 |
p. 6708-6711
4 p.
|
article
|
| 28 |
Improved design and intranasal delivery of an M2e-based human influenza A vaccine
|
De Filette, Marina
|
|
2006
|
24 |
44-46 |
p. 6597-6601
5 p.
|
article
|
| 29 |
Inflexal® V—The influenza vaccine with the lowest ovalbumin content
|
Kürsteiner, O.
|
|
2006
|
24 |
44-46 |
p. 6632-6635
4 p.
|
article
|
| 30 |
Influenza and pneumococcal vaccination coverage rates in Uppsala County, Sweden, during the winter of 2004-2005
|
|
|
2006
|
24 |
44-46 |
p. 6636-6637
2 p.
|
article
|
| 31 |
Influenza as an issue on the agenda of different stakeholders A multidisciplinary point of view
|
|
|
2006
|
24 |
44-46 |
p. 6796-6799
4 p.
|
article
|
| 32 |
Influenza as an issue on the agenda of health care workers: What can we do? What do we need?
|
|
|
2006
|
24 |
44-46 |
p. 6791-6792
2 p.
|
article
|
| 33 |
Influenza as an issue on the agenda of policy makers and government representatives What can we do? What do we need?
|
|
|
2006
|
24 |
44-46 |
p. 6793-6795
3 p.
|
article
|
| 34 |
Influenza A virus and the cell nucleus
|
Amorim, Maria Joao
|
|
2006
|
24 |
44-46 |
p. 6651-6655
5 p.
|
article
|
| 35 |
Influenza Surveillance: Why?
|
|
|
2006
|
24 |
44-46 |
p. 6770-6775
6 p.
|
article
|
| 36 |
Influenza vaccination in patients on long-term anticoagulant therapy
|
Iorio, A.M.
|
|
2006
|
24 |
44-46 |
p. 6624-6628
5 p.
|
article
|
| 37 |
Influenza work on the regional level in Sweden: An integrated program for vaccination of risk groups, surveillance and pandemic planning which focuses on the role of the health care worker
|
Stenqvist, Karin
|
|
2006
|
24 |
44-46 |
p. 6712-6716
5 p.
|
article
|
| 38 |
Interferon and other proinflamatory cytokine responses in vitro following infection with wild-type and cold-adapted reassortant influenza viruses
|
Rekstin, A.R.
|
|
2006
|
24 |
44-46 |
p. 6581-6584
4 p.
|
article
|
| 39 |
Misconceptions concerning influenza: An overview and clear answers
|
|
|
2006
|
24 |
44-46 |
p. 6779-6782
4 p.
|
article
|
| 40 |
Modelling the health-economic impact of the next influenza pandemic in The Netherlands
|
Hak, E.
|
|
2006
|
24 |
44-46 |
p. 6756-6760
5 p.
|
article
|
| 41 |
On the bias in HI titers and how to reduce it
|
Nauta, Jozef J.P.
|
|
2006
|
24 |
44-46 |
p. 6645-6646
2 p.
|
article
|
| 42 |
Pandemic preparedness: different perspectives How ready are we for the next pandemic?
|
|
|
2006
|
24 |
44-46 |
p. 6800-6806
7 p.
|
article
|
| 43 |
Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial
|
de Vrese, Michael
|
|
2006
|
24 |
44-46 |
p. 6670-6674
5 p.
|
article
|
| 44 |
Programme of the Community Network of Reference Laboratories for Human Influenza to Improve Influenza Surveillance in Europe
|
Meijer, Adam
|
|
2006
|
24 |
44-46 |
p. 6717-6723
7 p.
|
article
|
| 45 |
Real-time monitoring of the influenza vaccine field effectiveness
|
Legrand, Judith
|
|
2006
|
24 |
44-46 |
p. 6605-6611
7 p.
|
article
|
| 46 |
Reassortment between human A(H3N2) viruses is an important evolutionary mechanism
|
Schweiger, B.
|
|
2006
|
24 |
44-46 |
p. 6683-6690
8 p.
|
article
|
| 47 |
Recommendations and Guidelines on Influenza Vaccination and Treatment A key success factor
|
|
|
2006
|
24 |
44-46 |
p. 6783-6784
2 p.
|
article
|
| 48 |
Scientific lessons from the first influenza pandemic of the 20th century
|
Oxford, J.S.
|
|
2006
|
24 |
44-46 |
p. 6742-6746
5 p.
|
article
|
| 49 |
Single amino acid substitutions in the hemagglutinin of influenza A/Singapore/21/04 (H3N2) increase virus growth in embryonated chicken eggs
|
Lu, Bin
|
|
2006
|
24 |
44-46 |
p. 6691-6693
3 p.
|
article
|
| 50 |
Strategies for containing a global influenza pandemic
|
Flahault, Antoine
|
|
2006
|
24 |
44-46 |
p. 6751-6755
5 p.
|
article
|
| 51 |
The European CHMP criteria for influenza vaccine immunogenicity cannot be improved by the use of confidence intervals
|
Nauta, Jozef J.P.
|
|
2006
|
24 |
44-46 |
p. 6643-6644
2 p.
|
article
|
| 52 |
The humoral and cellular responses induced locally and systemically after parenteral influenza vaccination in man
|
Cox, Rebecca Jane
|
|
2006
|
24 |
44-46 |
p. 6577-6580
4 p.
|
article
|
| 53 |
The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice
|
Cox, Rebecca Jane
|
|
2006
|
24 |
44-46 |
p. 6585-6587
3 p.
|
article
|
| 54 |
The rapid identification of human influenza neuraminidase N1 and N2 subtypes by ELISA
|
Barr, I.G.
|
|
2006
|
24 |
44-46 |
p. 6675-6678
4 p.
|
article
|
| 55 |
The virosomal influenza vaccine Invivac®: Immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad®) in elderly subjects
|
de Bruijn, I.A.
|
|
2006
|
24 |
44-46 |
p. 6629-6631
3 p.
|
article
|
| 56 |
Towards improved influenza A virus surveillance in migrating birds
|
Munster, Vincent J.
|
|
2006
|
24 |
44-46 |
p. 6729-6733
5 p.
|
article
|
| 57 |
Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic
|
Viboud, Cécile
|
|
2006
|
24 |
44-46 |
p. 6701-6707
7 p.
|
article
|
| 58 |
Use of oseltamivir in Dutch nursing homes during the 2004–2005 influenza season
|
van der Sande, Marianne A.B.
|
|
2006
|
24 |
44-46 |
p. 6664-6669
6 p.
|
article
|
Journal description